Fluctuating Capacity and Demand Conditions in Biomanufacturing

Publication
Article
BioPharm InternationalBioPharm International-10-15-2015
Volume 2015 eBook
Issue 2

BioPharm International eBooks

BioPharm International

eBooks Volume 28, Issue 14  

Contract manufacturing is a booming business, especially considering that many pharmaceutical companies-including those with a focus on biologic products- are no longer conducting much of their own research and development in-house. Fewer still are capable of scaling up from laboratory to commercial production without some type of outside help from a contract manufacturing organization (CMO).    Read this article and other articles in

BioPharm International

's 2015

The Future of Bioprocessing

eBook.
 

Articles in this issue
BP1015-Fluctuating.gif
Fluctuating Capacity and Demand Conditions in Biomanufacturing
BP1015-Cleaning.gif
Cleaning Validation for Biologics
BP1015-Automation.gif
Automation of Single-Use Systems
BP1015-Aseptic.gif
Aseptic Processing for Cytotherapy, Regenerative Medicine, and Tissue-Engineered Products
BP1015-Patent.gif
Are Biopharma Patents Poised on the Post-Grant Chopping Block?
BP1015-Innovations.gif
Innovations in Automation—High-Throughput Dynamic Light Scattering for Screening Biotherapeutic Formulations
BP1015-Raising-the-bar.gif
Raising the Bar for Biopharma Training
Recent Videos
Behind the Headlines episode 5
Buy, Sell, Hold: Cell and Gene Therapy
Buy, Sell, Hold: Cell and Gene Therapy
Buy, Sell, Hold: Cell and Gene Therapy
Related Content
CDMO

5 CDMOs to Watch in 2025

Alicia Bigica
December 20th 2024
Article

Contract development and manufacturing organizations (CDMOs) are more critical than ever as the demand for advanced therapies continues to grow.

Drug Solutions Podcast: Considering Biologic Drug Development and Manufacturing Holistically

Drug Solutions Podcast: Considering Biologic Drug Development and Manufacturing Holistically

Felicity Thomas
May 25th 2023
Podcast

Hanns-Christian Mahler and Andrea Allmendinger from ten23 health will discuss some key aspects of biologic drug development and manufacturing.

Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

Lonza Launches Tailored Service for Smart Capsule Development for Oral Biologics

Feliza Mirasol
December 3rd 2024
Article

Lonza’s new tailored offering leverages the company’s bi-layer capsule manufacturing technology.

Blockchain concept 3d rendering with blue cubes and chains stands.as cryptocurrency digital code chain. | Image Credit: ©kugelwolf - Stock.adobe.com

How Modularization and Digital Delivery are Transforming Pharma Manufacturing

Jordan Ulrich;Dana Tilley
November 26th 2024
Article

Modular and replication strategies are being utilized to meet growing demand for CDMO facilities.

Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

Fujifilm Completes Expansion of Cell Therapy Facility

Nicholas Saraceno
November 22nd 2024
Article

The company officially launched new production suites, a revamp of its development labs, and more at its Thousand Oaks, Calif., cell therapy manufacturing facility.

Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

Abzena Launches GMP Cell-Based Potency Testing in US and UK Sites, Boosting Analytical Capabilities

Feliza Mirasol
November 22nd 2024
Article

The company will now include GMP cell-based potency assays at its Cambridge, UK, and San Diego, Calif., sites expanding its early and late phase analytical capabilities.

© 2024 MJH Life Sciences

All rights reserved.